Large-scale (Phase III) evaluation of broflanilide 50WP (VECTRON™ T500) for indoor residual spraying for malaria vector control in Northeast Tanzania: study protocol for a two-arm, non-inferiority, cluster-randomised community trial (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12879-022-07138-3
PubMed Identifier: 35189830
Publication URI: http://europepmc.org/abstract/MED/35189830
Type: Journal Article/Review
Parent Publication: BMC Infectious Diseases
Issue: 1
ISSN: 1471-2334